Kusajili – Centralise les essais cliniques mondiaux

Votre recherche

Source: nct - Pays: Germany,Australia,Romania,Russian Federation,Poland,Japan,Denmark,Netherlands,Argentina - Phase: complete

Vicente Torres, MD, PhD MAJ Il y a 5 ans

Tolvaptan Phase 3 Efficacy and Safety Study in ADPKD This study's purpose is to evaluate the long-term safety and efficacy of tolvaptan versus placebo in patients with ADPKD.

Pays Argentina, Australia, Belgium, Canada, Denmark, France, Germany, Italy, Japan, Netherlands, Poland, Romania, Russian Federation, United Kingdom, United States,
Organes Aucun
Spécialités Aucun

Essai clos aux inclusions

Plus d'informations

1